Document is current
Any future updates will be listed below
-
Authors
Chopard, Romain http://orcid.org/0000-0002-8358-515X
Jimenez, David
Serzian, Guillaume
Ecarnot, Fiona
Falvo, Nicolas
Kalbacher, Elsa
Bonnet, Benjamin
Capellier, Gilles
Schiele, François
Bertoletti, Laurent
Monreal, Manuel
Meneveau, Nicolas
-
Funding
Funding for this research was provided by:
BMS-Pfizer
Bayer Healthcare SAS
- License Information
-
More Information
Article History
Received: 8 October 2020
Accepted: 1 January 2021
First Online: 9 February 2021
Ethics approval and consent to participate
: This registry received approval from the national commission for data privacy and protection. This study was conducted in accordance with the amended Declaration of Helsinki. All patients provided written informed consent, and our institutional review board approved the study.
: Not applicable.
: M. Monreal reports receiving fees for advisory issues from Sanofi, Leo Pharma, and Bristol Myers Squibb, outside of the submitted work. N Meneveau reports receiving consultancy fees from Abbott, BMS-Pfizer, Bayer Healthcare, Edwards Lifesciences, Terumo, outside of the submitted work. F. Schiele reports receiving speaker’s bureau fees from Amgen, Astra Zeneca, Bayer Healthcare, Boehringer Ingelheim, MSD, Pfizer, Sanofi Aventis, and Terumo. Dr. Bertoletti reports personal fees and non-financial support from BAYER, personal fees and non-financial support from LEO-PHARMA, personal fees and non-financial support from ASPEN, personal fees and non-financial support from BMS-PFIZER, non-financial support from DAIICHI, outside the submitted work. No other author has any conflicts of interest to declare.
